Lidokain-Adrenalin Sad

Lidocaine Hydrochloride, the active ingredient in Lidokain-Adrenalin Sad, is a local anesthetic presented as a solution for intramuscular and subcutaneous use. It provides rapid numbness of tissue for minor surgical or dental procedures in adult patients and helps facilitate painless wound closure.

GNH USA supplies Lidokain-Adrenalin Sad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across EU and other markets.

Lidokain-Adrenalin Sad, a combination of lidocaine and epinephrine, is employed in local anesthesia for procedures involving soft tissue.

Dental procedures: provides rapid onset numbness and reduces bleeding during extractions or restorative work. Minor skin surgery: enables painless excision of lesions and controls intra‑operative bleeding. Suturing of small lacerations: facilitates comfortable wound closure with prolonged anesthetic effect.

Adverse reactions to Lidokain-Adrenalin Sad may vary in frequency and severity.

Common Side Effects: - Transient burning or stinging at the injection site - Mild dizziness or light‑headedness - Nausea - Tachycardia due to epinephrine

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiac arrhythmias or myocardial ischemia - Persistent numbness or neurological deficits

When using Lidokain-Adrenalin Sad, consider the following precautions.

Allergy assessment: verify no known hypersensitivity to lidocaine, epinephrine or amide‑type anesthetics. Cardiovascular status: use cautiously in patients with uncontrolled hypertension, arrhythmias, or ischemic heart disease. Dosage limits: avoid exceeding recommended maximum lidocaine dose to prevent systemic toxicity. Pregnancy and lactation: consider risk‑benefit; limited data, use only if clearly needed. Drug interactions: review concomitant medications that may potentiate epinephrine effects. Store at room temperature: keep in original container, protect from light and moisture.

Lidokain-Adrenalin Sad may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase lidocaine plasma levels and toxicity. - Beta‑blockers (e.g., propranolol): can potentiate epinephrine‑induced hypertension and tachycardia. - Monoamine oxidase inhibitors: may enhance epinephrine effects.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase bleeding risk when combined with epinephrine vasoconstriction. - Diuretics (e.g., furosemide): may reduce plasma volume, altering lidocaine distribution. - Tricyclic antidepressants: may lower seizure threshold when combined with lidocaine.